Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2019-10-31

FDA Approved: CAREONE ALLERGY RELIEF — Supplemental Application (American Sales Company)

View source ↗

Summary

FDA approved a supplemental application for CAREONE ALLERGY RELIEF containing fexofenadine HCl, submitted by American Sales Company.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CAREONE ALLERGY RELIEF (FEXOFENADINE HCL)

Snippet

SUPPL AP for CAREONE ALLERGY RELIEF (FEXOFENADINE HCL)